U.S. Markets closed

Interpace Biosciences, Inc. (IDXG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.74+0.05 (+0.58%)
At close: 2:11PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.51
52 Week Low 32.57
50-Day Moving Average 39.86
200-Day Moving Average 37.09

Share Statistics

Avg Vol (3 month) 312.45k
Avg Vol (10 day) 312.56k
Shares Outstanding 54.11M
Implied Shares Outstanding 6N/A
Float 3.43M
% Held by Insiders 126.70%
% Held by Institutions 10.32%
Shares Short (Feb 11, 2021) 447.35k
Short Ratio (Feb 11, 2021) 40.19
Short % of Float (Feb 11, 2021) 41.18%
Short % of Shares Outstanding (Feb 11, 2021) 41.17%
Shares Short (prior month Jan 14, 2021) 468.56k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 14, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 14, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -72.84%
Operating Margin (ttm)-68.80%

Management Effectiveness

Return on Assets (ttm)-23.31%
Return on Equity (ttm)-71.40%

Income Statement

Revenue (ttm)33.17M
Revenue Per Share (ttm)8.19
Quarterly Revenue Growth (yoy)8.50%
Gross Profit (ttm)10.72M
EBITDA -17.21M
Net Income Avi to Common (ttm)-23.93M
Diluted EPS (ttm)-5.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.84M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)9.57M
Total Debt/Equity (mrq)70.19
Current Ratio (mrq)0.70
Book Value Per Share (mrq)-8.00

Cash Flow Statement

Operating Cash Flow (ttm)-11.86M
Levered Free Cash Flow (ttm)-4.96M